U.S. Communications Stock News

NYSE:MEG
NYSE:MEGCommercial Services

Is It Too Late To Consider Montrose Environmental Group (MEG) After Its Recent Share Price Surge?

Wondering if Montrose Environmental Group at around US$29.22 is offering fair value today, or if the recent excitement has already been priced in? The stock has logged returns of 26.5% over the last 7 days, 30.2% over the last 30 days, 17.4% year to date and 50.4% over the last year, while the 3 year and 5 year returns sit at 21.4% and 28.6% declines. This price action comes as investors continue to assess Montrose Environmental Group's position in environmental services and its execution on...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

A Look At Keurig Dr Pepper (KDP) Valuation After Recent Share Price Momentum

Why Keurig Dr Pepper is on investors’ radar today Keurig Dr Pepper (KDP) has drawn attention after recent share price moves, with the stock showing gains over the past week, month, and past 3 months that contrast with weaker one year returns. See our latest analysis for Keurig Dr Pepper. The recent 30 day share price return of 13.37% and 90 day share price return of 8.53% sit against a 1 year total shareholder return of a 6.83% decline. This suggests momentum has picked up lately after a...
NYSE:DKS
NYSE:DKSSpecialty Retail

Is DICK'S Sporting Goods (DKS) Pricing Look Reasonable After Mixed Long Term Returns

If you are wondering whether DICK'S Sporting Goods is fairly priced at around US$204.22 a share, this article walks through what that number might and might not be telling you. The stock has had mixed returns, with a 1% decline over the last 7 days, a 0.7% decline over 30 days, a 2% gain year to date and a 7.1% decline over 1 year. The 3 year return sits at 66.4% and the 5 year return is very large at about 3x. Recent attention on DICK'S Sporting Goods has focused on how a well known US...
NYSE:ESRT
NYSE:ESRTOffice REITs

Is Empire State Realty Trust (ESRT) Pricing Reflect Long-Term Office Demand Concerns?

If you are wondering whether Empire State Realty Trust's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. The stock last closed at US$5.88, with returns of 0.8% decline over 7 days, 9.8% decline over 30 days, 9.1% decline year to date and 35.4% decline over 1 year. This naturally raises questions about whether the market is reassessing its risks or overlooking potential. Recent coverage around...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Fulton Financial’s Blue Foundry Deal Clears Regulators And Raises Integration Focus

Fulton Financial has received all required regulatory approvals to acquire Blue Foundry Bancorp. The approvals clear a major hurdle in the merger process, with closing now subject to remaining conditions. The transaction is set to expand Fulton Financial's regional footprint and reshape its organizational scope once completed. For investors watching NasdaqGS:FULT, the regulatory green light lands at a time when the shares are trading at $20.45. Over the past 3 years the stock has returned...
NasdaqGS:ANDE
NasdaqGS:ANDEConsumer Retailing

Andersons Expands Ethanol Capacity And Infrastructure As Valuation Signals Upside

Andersons (NasdaqGS:ANDE) plans to expand ethanol production capacity by about 30 million gallons starting in 2027. The company is pairing this expansion with infrastructure upgrades across its operations. These moves follow record fourth quarter earnings, supported by a strong fall harvest and solid export demand. For you as an investor, this update ties directly to how Andersons positions itself across agriculture and renewables. The company operates in grain merchandising, plant...
NYSE:FNF
NYSE:FNFInsurance

Assessing Fidelity National Financial (FNF) Valuation After Mixed Earnings And Volatile Analyst And Options Signals

Fidelity National Financial (FNF) has moved into focus after mixed quarterly results, a fresh dividend declaration, and a pickup in options activity, all against a backdrop of conflicting analyst opinions on the stock. See our latest analysis for Fidelity National Financial. The recent quarterly loss, dividend confirmation and ongoing buybacks come after a 90 day share price return of an 11.02% decline and a 1 year total shareholder return of a 12% decline. However, the 3 year and 5 year...
NYSE:NRP
NYSE:NRPOil and Gas

Is It Time To Reassess Natural Resource Partners (NRP) After Its Multi Year Rally

If you are looking at Natural Resource Partners and wondering whether the current price reflects its true value, this article will walk you through what the numbers are really saying. The stock closed at US$121.05, with returns of a 1.8% decline over 7 days, 6.0% over 30 days, 16.4% year to date, 19.6% over 1 year and a very large gain over 5 years. This naturally raises questions about how the current price stacks up against fundamentals. Recent interest in Natural Resource Partners has...
NasdaqGS:FIGR
NasdaqGS:FIGRConsumer Finance

Figure Technology Solutions (FIGR) 31% Net Margin Reinforces Bullish Profitability Narrative

Figure Technology Solutions (FIGR) FY 2025 Earnings Snapshot Figure Technology Solutions (FIGR) has capped FY 2025 with Q4 revenue of US$135.6 million and basic EPS of US$0.07, alongside trailing twelve month revenue of US$432.1 million and EPS of US$1.17 that put the latest figures into a fuller context. The company has seen quarterly revenue move from US$67.9 million in Q1 2025 to US$90.0 million in Q2, US$138.5 million in Q3 and US$135.6 million in Q4, while basic EPS has ranged from a...
NYSE:BKU
NYSE:BKUBanks

A Look At BankUnited (BKU) Valuation After Solid Results And Slower Net Interest Income Growth

Recent commentary around BankUnited (BKU) focuses on its solid quarterly results, which have supported recent share price gains, while also highlighting slower net interest income growth and the possibility of a less efficient cost base ahead. See our latest analysis for BankUnited. At a latest share price of $46.70, the 1 day and 7 day share price returns of 5.62% and 6.73% declines contrast with a 90 day share price return of 8.08% and a 1 year total shareholder return of 28.47%. This...
NYSE:BFLY
NYSE:BFLYMedical Equipment

Assessing Butterfly Network’s Valuation After Record Q4 Growth And First Positive Operating Cash Flow

Butterfly Network (BFLY) is back on investors’ radar after reporting record fourth quarter revenue, 41% year-over-year growth and its first quarter of positive operating cash flow, supported by its Butterfly Embedded platform and Midjourney partnership. See our latest analysis for Butterfly Network. The share price has been volatile around the recent earnings and guidance, with a 27.18% 7 day share price return reversing sharply into an 18.84% 1 day decline. At the same time, the 1 year total...
NYSE:OXY
NYSE:OXYOil and Gas

Is Occidental Petroleum (OXY) Pricing Reflect Long Term Value After Mixed Share Performance

If you are wondering whether Occidental Petroleum's current share price really reflects what you are getting for your money, this article walks through the numbers so you can judge the value for yourself. The stock last closed at US$53.08, with returns of 2.4% over 7 days, 18.4% over 30 days, 25.2% year to date, 11.1% over 1 year, negative 8.9% over 3 years and 80.4% over 5 years. This gives you a mixed picture to keep in mind as you weigh the valuation. Recent coverage of Occidental has...
NYSE:OTIS
NYSE:OTISMachinery

A Look At Otis Worldwide (OTIS) Valuation After Launch Of Arise MOD Elevator Modernization Packages

Otis Worldwide (OTIS) has introduced its Arise MOD Prime and Arise MOD Plus elevator modernization packages in North America, giving building owners more choice over how they update low to mid rise residential and commercial elevators. See our latest analysis for Otis Worldwide. At a share price of US$92.56, Otis has a 30 day share price return of 4.47%. Its 1 year total shareholder return shows a 5.52% decline, which contrasts with a 54.07% total shareholder return over five years and...
NasdaqCM:ABTC
NasdaqCM:ABTCSoftware

American Bitcoin (ABTC) Revenue Surge With FY 2025 Loss Tests Bullish Growth Narratives

American Bitcoin (ABTC) has closed out FY 2025 with Q4 revenue of US$78.3 million and a basic EPS loss of US$0.06, alongside trailing twelve month revenue of US$185.2 million and EPS of US$0.17. Over the past few quarters the company has seen revenue move from US$11.6 million in Q3 2024 to US$12.3 million in Q1 2025, US$30.3 million in Q2 2025, US$64.2 million in Q3 2025 and US$78.3 million in Q4 2025, while quarterly EPS has ranged from a loss of US$1.99 in Q1 2025 to a profit of US$0.06 in...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Monster Beverage (MNST) Margin Expansion Reinforces Bull Narratives Despite Rich P/E

Monster Beverage (MNST) closed out FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$0.46, alongside trailing twelve month revenue of US$8.3 billion and EPS of US$1.95 that followed earnings growth of 26.3% over the last year. Over recent periods, the company has seen quarterly revenue move from US$1.9 billion in Q3 2024 to US$2.0 billion in Q4 2024, then to US$1.9 billion in Q1 2025 and US$2.1 billion in both Q2 and Q4 2025, while basic EPS shifted from US$0.38 in Q3...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis FDA And Phase 3 Updates Reframe Rare Disease Valuation Story

Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA Priority Review for olezarsen in severe hypertriglyceridemia, indicating an expedited regulatory timeline. New Phase 3 analyses for DAWNZERA, an RNA targeted therapy for hereditary angioedema, are scheduled for presentation at a major scientific forum. These developments focus on two rare disease programs that are central to Ionis’s drug development efforts. Ionis Pharmaceuticals focuses on RNA targeted medicines, with a portfolio that...
NYSE:BRSL
NYSE:BRSLHospitality

Brightstar Lottery Board Shifts Test Capital Returns And Italy Growth Plan

Brightstar Lottery (NYSE:BRSL) has appointed Mariangela Zappia, an international diplomat, as an independent director to its board. The company has announced that CFO Max Chiara will not stand for board re election, with his departure expected after the upcoming shareholder meeting. Brightstar recently secured a nine year renewal of the Italy Lotto licence, supporting a multiyear capital allocation plan and expansion initiatives. Brightstar Lottery, listed on the NYSE under ticker BRSL,...
NYSE:FR
NYSE:FRIndustrial REITs

A Look At First Industrial Realty Trust’s Valuation After Land & Buildings’ Activist Letter And Board Challenge

Why the activist letter matters for First Industrial Realty Trust (FR) On February 26, Land & Buildings Investment Management publicly challenged First Industrial Realty Trust (FR), criticizing its boardroom culture and urging changes it says are needed to address the REIT’s trading discount and unlock more value. See our latest analysis for First Industrial Realty Trust. At a share price of US$63.14, First Industrial Realty Trust has logged an 11.03% 1 month share price return and a 14.42% 1...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

Olema Pharmaceuticals (OLMA) Valuation Check After Recent Share Price Volatility

Olema Pharmaceuticals (OLMA) has been drawing attention after recent share price swings, with the stock at US$24.20 and mixed returns over the past month, past 3 months, and year to date, prompting fresh investor scrutiny. See our latest analysis for Olema Pharmaceuticals. While the recent 1 day and 30 day share price returns show modest declines from US$24.20, the very large 1 year and 3 year total shareholder returns suggest earlier optimism around Olema Pharmaceuticals is now being...
NYSE:ESTC
NYSE:ESTCSoftware

Elastic ESTC Swings To Q3 Profit Challenging Persistent Loss Making Narrative

Q3 2026 results set up a cleaner earnings story for Elastic (ESTC) Elastic (ESTC) has just posted Q3 2026 revenue of US$449.9 million with basic EPS of US$0.07, alongside trailing twelve month revenue of about US$1.7 billion and a basic EPS loss of US$0.80, giving investors a clearer read on both recent momentum and the still negative full year earnings base. The company has seen quarterly revenue move from US$365.4 million in Q2 2025 to US$449.9 million in Q3 2026, while basic EPS has...
NYSE:BURL
NYSE:BURLSpecialty Retail

Burlington’s 2026 Expansion Plans Test Valuation And Debt Profile

Burlington Stores (NYSE:BURL) plans to open 110 net new stores in 2026, ahead of earlier expectations. The company is also expanding its corporate office footprint in New York to support a larger organization. These moves reflect management's intent to scale operations and reinforce Burlington's long term growth plans. Burlington Stores comes into this announcement with its shares at $306.62 and a 1 year return of 23.0%. Over 3 years the stock has returned 41.8%, and over 5 years 9.8%,...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

Nutex Health (NUTX) Is Up 9.3% After Profitability And Valuation Analysis Sparks Investor Interest

Recent analysis of Nutex Health’s hybrid model of micro-hospitals, hospital management services, and population health programs highlighted strong profitability metrics and claims of deep undervaluation, drawing fresh investor attention in the past week. An interesting angle is the company’s high free cash flow conversion, which some commentators argue could support a meaningful reassessment of its valuation if operating performance holds. We’ll now examine how Nutex Health’s highlighted...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera (ABCL) Is Up 18.8% After Pivoting To Clinical Stage And Filing Share Offering

AbCellera Biologics Inc. has reported its full-year 2025 results, with revenue rising to US$75.13 million and net loss easing to US$146.41 million, while also filing a US$45.54 million shelf registration for 15,030,034 common shares tied to an employee share offering. Alongside these financials, AbCellera’s shift into a clinical-stage biotech with advancing programs ABCL635 and ABCL575 and a nearly completed manufacturing facility signals a business model increasingly centered on internal...
NYSE:ARLO
NYSE:ARLOElectronic

Arlo Technologies (ARLO) Earnings Turn Positive Challenging Skeptical Profitability Narratives

Arlo Technologies (ARLO) closed out FY 2025 with Q4 revenue of US$141.3 million and basic EPS of US$0.05, alongside net income of US$5.8 million. The trailing 12 month line shows revenue of US$529.3 million and basic EPS of US$0.14 as the business moves further into consistent profitability. Over the past six quarters, the company has seen revenue range from US$119.1 million to US$141.3 million per quarter, with basic EPS shifting from a loss of US$0.05 in late 2024 to positive contributions...